Magnetar Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.94M | Buy |
+32,473
| New | +$1.89M | 0.02% | 323 |
|
|
2025
Q4 | – | Sell |
-8,874
| Closed | -$400K | – | 953 |
|
|
2025
Q3 | $400K | Sell |
8,874
-33,647
| -79% | -$1.57M | ﹤0.01% | 639 |
|
|
2025
Q2 | $1.97M | Buy |
+42,521
| New | +$2.09M | 0.01% | 348 |
|
|
2025
Q1 | – | Sell |
-216,407
| Closed | -$12.2M | – | 748 |
|
|
2024
Q4 | $12.2M | Buy |
216,407
+182,616
| +540% | +$10.2M | 0.28% | 89 |
|
|
2024
Q3 | $1.75M | Buy |
33,791
+18,484
| +121% | +$867K | 0.04% | 239 |
|
|
2024
Q2 | $636K | Buy |
+15,307
| New | +$685K | 0.01% | 316 |
|
|
2024
Q1 | – | Sell |
-28,476
| Closed | -$1.46M | – | 383 |
|
|
2023
Q4 | $1.46M | Sell |
28,476
-76,660
| -73% | -$4.02M | 0.04% | 224 |
|
|
2023
Q3 | $6.1M | Buy |
105,136
+98,098
| +1,394% | +$6.01M | 0.16% | 101 |
|
|
2023
Q2 | $450K | Buy |
+7,038
| New | +$472K | 0.01% | 354 |
|
|
2023
Q1 | – | Sell |
-6,639
| Closed | -$478K | – | 618 |
|
|
2022
Q4 | $478K | Sell |
6,639
-323,650
| -98% | -$24.4M | 0.01% | 611 |
|
|
2022
Q3 | $23.5M | Buy |
330,289
+317,210
| +2,425% | +$23M | 0.33% | 64 |
|
|
2022
Q2 | $1.01K | Buy |
+13,079
| New | +$996K | 0.01% | 971 |
|
|
2022
Q1 | – | Sell |
-322,833
| Closed | -$20.1M | – | 1345 |
|
|
2021
Q4 | $20.1M | Sell |
322,833
-24,710
| -7% | -$1.45M | 0.2% | 97 |
|
|
2021
Q3 | $20.6M | Buy |
347,543
+66,485
| +24% | +$4.38M | 0.21% | 92 |
|
|
2021
Q2 | $18.8K | Buy |
+281,058
| New | +$18.3M | 0.18% | 116 |
|
|
2021
Q1 | – | Sell |
-44,603
| Closed | -$2.77M | – | 1050 |
|
|
2020
Q4 | $2.77M | Sell |
44,603
-21,060
| -32% | -$1.29M | 0.04% | 300 |
|
|
2020
Q3 | $3.96M | Sell |
65,663
-19,265
| -23% | -$1.16M | 0.07% | 197 |
|
|
2020
Q2 | $4.99M | Sell |
84,928
-26,913
| -24% | -$1.61M | 0.15% | 120 |
|
|
2020
Q1 | $6.23M | Buy |
111,841
+51,798
| +86% | +$3.17M | 0.15% | 110 |
|
|
2019
Q4 | $3.85M | Sell |
60,043
-46,899
| -44% | -$2.69M | 0.08% | 132 |
|
|
2019
Q3 | $5.42M | Sell |
106,942
-131,721
| -55% | -$6.19M | 0.14% | 100 |
|
|
2019
Q2 | $10.8M | Buy |
+238,663
| New | +$11.1M | 0.22% | 60 |
|
|
2016
Q4 | – | Sell |
-6,858
| Closed | -$370K | – | 62 |
|
|
2016
Q3 | $370K | Sell |
6,858
-7,820
| -53% | -$502K | 0.01% | 423 |
|
|
2016
Q2 | $1.08M | Buy |
14,678
+8,334
| +131% | +$589K | 0.02% | 163 |
|
|
2016
Q1 | $405K | Buy |
+6,344
| New | +$400K | 0.01% | 226 |
|
|
2015
Q4 | – | Sell |
-6,924
| Closed | -$410K | – | 367 |
|
|
2015
Q3 | $410K | Buy |
+6,924
| New | +$439K | 0.01% | 266 |
|
|
2015
Q2 | – | Sell |
-34,896
| Closed | -$2.25M | – | 427 |
|
|
2015
Q1 | $2.25M | Buy |
+34,896
| New | +$2.18M | 0.04% | 146 |
|
|
2014
Q4 | – | Sell |
-28,631
| Closed | -$1.47M | – | 181 |
|
|
2014
Q3 | $1.47M | Buy |
+28,631
| New | +$1.43M | 0.02% | 136 |
|
Other funds holding BMY
VCM
VPM
Magnetar Financial's BMY Position: Q1 2026 in Review
Magnetar Financial opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 32,473 shares worth $1.94M. The stake represents 0.02% of the portfolio and ranks #323 among its holdings. This is a return to the name: Magnetar Financial previously reported a position in BMY as recently as Q3 2025.
Magnetar Financial first reported a position in BMY in Q3 2014 and has held it in 28 quarters since. The position peaked at $23.5M in Q3 2022. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Magnetar Financial held 32,473 shares of Bristol-Myers Squibb worth $1.94M as of Q1 2026.
- Bristol-Myers Squibb was a new Magnetar Financial position in Q1 2026.
- Bristol-Myers Squibb made up 0.02% of Magnetar Financial's portfolio in Q1 2026, its #323 holding.
- Magnetar Financial first reported a position in Bristol-Myers Squibb in Q3 2014 and has held it in 28 quarters since.
- Magnetar Financial's Bristol-Myers Squibb position peaked at $23.5M in Q3 2022.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.